Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01722188 · ClinicalTrials.gov registry record
Lead Registry for Optim Leads
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 14,124
- Enrollment target
NCT01722188 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 14,124 participants.
The verdict
NCT01722188 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 14,124 participants
- Enrollment target
Study Summary
This is a prospective, multi-center, actively monitored, long term data collection registry. Any Patient that receives a market released St. Jude Medical (SJM) Optim lead and a compatible market released cardia rhythm management (CRM) implantable pulse generator is eligible for enrollment into the registry.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14,124 participants |
| Start Date | 2006-08 |
| Est. Completion | 2020-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01722188
The ClinicalTrials.gov registry entry for NCT01722188 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 14,124 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01722188 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01722188 about?
NCT01722188 is a clinical study titled "Lead Registry for Optim Leads". This is a prospective, multi-center, actively monitored, long term data collection registry. Any Patient that receives a market released St. Jude Medical (SJM) Optim lead and a compatible market released cardia rhythm management (CRM) implantable pulse generator is eligible for enrollment into the r...
What is the current status of trial NCT01722188?
This trial is currently completed. The enrollment target is 14,124 participants. The study started on 2006-08. Estimated completion is 2020-07.
Who is sponsoring clinical trial NCT01722188?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.